[HTML][HTML] Inducing immune tolerance with dendritic cell-targeting nanomedicines

A Cifuentes-Rius, A Desai, D Yuen… - Nature …, 2021 - nature.com
Induced tolerogenic dendritic cells are a powerful immunotherapy for autoimmune disease
that have shown promise in laboratory models of disease and early clinical trials. In contrast …

Inducing immune tolerance with dendritic cell-targeting nanomedicines

A Cifuentes-Rius, A Desai, D Yuen… - Nature …, 2021 - research.monash.edu
Induced tolerogenic dendritic cells are a powerful immunotherapy for autoimmune disease
that have shown promise in laboratory models of disease and early clinical trials. In contrast …

Inducing immune tolerance with dendritic cell-targeting nanomedicines

A Cifuentes-Rius, A Desai, D Yuen… - Nature …, 2021 - pubmed.ncbi.nlm.nih.gov
Induced tolerogenic dendritic cells are a powerful immunotherapy for autoimmune disease
that have shown promise in laboratory models of disease and early clinical trials. In contrast …

Inducing immune tolerance with dendritic cell-targeting nanomedicines.

A Cifuentes-Rius, A Desai, D Yuen… - Nature …, 2020 - europepmc.org
Induced tolerogenic dendritic cells are a powerful immunotherapy for autoimmune disease
that have shown promise in laboratory models of disease and early clinical trials. In contrast …

Inducing immune tolerance with dendritic cell-targeting nanomedicines

A Cifuentes-Rius, A Desai, D Yuen… - Nature …, 2021 - ui.adsabs.harvard.edu
Induced tolerogenic dendritic cells are a powerful immunotherapy for autoimmune disease
that have shown promise in laboratory models of disease and early clinical trials. In contrast …

[引用][C] Inducing immune tolerance with dendritic cell-targeting nanomedicines

A Cifuentes-Rius, A Desai, D Yuen, APR Johnston… - research.monash.edu
Inducing immune tolerance with dendritic cell-targeting nanomedicines – Equipment — Monash
University Skip to main navigation Skip to search Skip to main content Monash University Home …